CytoMed Therapeutics Limited Company Information

CytoMed Therapeutics Limited's employee growth, exchange listings and data sources

Key Information

Name: CytoMed Therapeutics Limited
Ticker: F98
Exchange: DB
Founded: 2018
Industry: Biotechnology
Sector: Pharmaceuticals & Biotech
Market Cap: US$26.075m
Listing Market Cap: US$25.039m
Shares Outstanding: 11.54m
Website: https://w2.cytomed.sg

Location

CytoMed Therapeutics Limited
1 Commonwealth Lane, No. 08-22
Singapore
149544
Singapore

Listings

Ticker	Exchange	Primary Security	Security Type	Country	Currency	Listed on
GDTC	NasdaqCM (Nasdaq Capital Market)	Yes	Ordinary Shares	US	USD	Apr 2023
F98	DB (Deutsche Boerse AG)	Yes	Ordinary Shares	DE	EUR	Apr 2023

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
Data	Last Updated (UTC time)
Company Analysis	2024/11/24 03:10
End of Day Share Price	2024/11/22 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.